As of 2025-05-17, the Intrinsic Value of CME Group Inc (CME) is 267.94 USD. This CME valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 276.29 USD, the upside of CME Group Inc is -3.00%.
The range of the Intrinsic Value is 158.79 - 972.54 USD
Based on its market price of 276.29 USD and our intrinsic valuation, CME Group Inc (CME) is overvalued by 3.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 158.79 - 972.54 | 267.94 | -3.0% |
| DCF (Growth 10y) | 156.30 - 858.44 | 251.35 | -9.0% |
| DCF (EBITDA 5y) | 193.15 - 231.83 | 214.14 | -22.5% |
| DCF (EBITDA 10y) | 181.76 - 234.84 | 208.34 | -24.6% |
| Fair Value | 112.62 - 112.62 | 112.62 | -59.24% |
| P/E | 282.59 - 367.93 | 325.19 | 17.7% |
| EV/EBITDA | 227.81 - 270.00 | 253.05 | -8.4% |
| EPV | 207.01 - 298.03 | 252.52 | -8.6% |
| DDM - Stable | 128.53 - 988.20 | 558.36 | 102.1% |
| DDM - Multi | 154.13 - 810.21 | 248.46 | -10.1% |
| Market Cap (mil) | 99,569.39 |
| Beta | 0.17 |
| Outstanding shares (mil) | 360.38 |
| Enterprise Value (mil) | 101,640.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.20% |
| Cost of Debt | 4.25% |
| WACC | 7.07% |